Showing posts with label AI medical uses. Show all posts
Showing posts with label AI medical uses. Show all posts

Sunday, April 26, 2026

Teen, 14, Invents AI-Powered Device to Help Detect, and Potentially Treat, Crossed Eyes; People, April 26, 2026

Toria Sheffield, People; Teen, 14, Invents AI-Powered Device to Help Detect, and Potentially Treat, Crossed Eyes

 "An 8th grader in California has invented an AI-powered device to help detect — and potentially treat — strabismus, a condition commonly known as crossed eyes.

Aaryan Balani of Cerritos said he opted to develop the device since he personally suffers from strabismus. The 14-year-old developed the condition after bumping his head when he was five years old...  

The young science aficionado decided to develop EYEVA, a device that looks like a visor and alerts the wearer when their eye begins to wander.

"It will beep … and you're like, ‘Okay, now I need to be aware of my face," Balani explained, adding that, in theory, it could help the wearer permanently retrain their eyes.

Balani said he developed the device with a 3D printer, small cameras and AI. It went through five different prototypes and four months of tweaking."

Wednesday, March 26, 2025

Doctors Told Him He Was Going to Die. Then A.I. Saved His Life.; The New York Times, March 20, 2025

, The New York Times ; Doctors Told Him He Was Going to Die. Then A.I. Saved His Life.

"In labs around the world, scientists are using A.I. to search among existing medicines for treatments that work for rare diseases. Drug repurposing, as it’s called, is not new, but the use of machine learning is speeding up the process — and could expand the treatment possibilities for people with rare diseases and few options.

Thanks to versions of the technology developed by Dr. Fajgenbaum’s team at the University of Pennsylvania and elsewhere, drugs are being quickly repurposed for conditions including rare and aggressive cancers, fatal inflammatory disorders and complex neurological conditions. And often, they’re working."